Systemic Lupus Erythematosus
📧 Sign up to get email alerts when something new happens for Systemic Lupus Erythematosus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-06-29Clinical Trial Update: AGR+PNI as Predictors of Systemic Lupus Erythematosus Disease Activity
This ClinicalTrials.gov entry describes a study investigating AGR+PNI as predictors of disease activity in systemic lupus erythematosus, wit…
-
FDA approval · 2025-06-27FDA Approved: MYHIBBIN — Supplemental Application (Azurity Pharmaceuticals, Inc.)
FDA approved a supplemental application for MYHIBBIN (mycophenolate mofetil) submitted by Azurity Pharmaceuticals, Inc. The supplement perta…
-
CLINICAL_TRIALS research · 2025-06-27Clinical Trial Update: Treatment of Systemic Lupus Erythematosus With Human Umbilical Cord Mesenchymal Stem Cells [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating human umbilical cord mesenchymal stem cells for systemic lupus erythematosus. The study is currentl…
-
CLINICAL_TRIALS research · 2025-06-24Clinical Trial Update: AZAHAR Study To Describe Anifrolumab in a Real-World Setting
An observational real-world study update detailing the use of Anifrolumab in systemic lupus erythematosus (SLE) from the AZAHAR study. The s…
-
CLINICAL_TRIALS research · 2025-06-24Clinical Trial Update: A Study of GNC-038 Tetra-specific Antibody Injection in Patients With Systemic Lupus Erythematosus [Phase 1]
An ongoing Phase 1 clinical trial evaluating GNC-038, a tetra-specific antibody, in patients with systemic lupus erythematosus, sponsored by…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-06-20FDA Approved: BENLYSTA — Supplemental Application (GlaxoSmithKline LLC)
The FDA approved a supplemental application for Benlysta (belimumab) submitted by GlaxoSmithKline LLC.
-
FDA approval · 2025-06-13FDA Approved: HYDROXYCHLOROQUINE — Supplemental Application (Chartwell RX, LLC)
The FDA approved a supplemental application for hydroxychloroquine (HYDROXYCHLOROQUINE) from Chartwell RX, LLC under an ANDA. The action upd…
-
FDA approval · 2025-06-13FDA Approved: AZATHIOPRINE — Supplemental Application (Ascend Laboratories, LLC)
The FDA approved a supplemental application for azathioprine from Ascend Laboratories, LLC.
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: Correlation Between Serum Uric Acid, Serum Homocysteine Level and Interleukin- 17 in Lupus Nephritis Patients
A recruiting clinical trial examining the relationships between serum uric acid, serum homocysteine, and interleukin-17 levels in patients w…
-
CLINICAL_TRIALS research · 2025-06-10Clinical Trial Update: A Study Evaluating the Efficacy and Safety of Afimetoran Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE) [Phase 2]
A Phase 2 study is evaluating Afimetoran versus placebo in active systemic lupus erythematosus, with the trial currently active but not recr…
-
CLINICAL_TRIALS research · 2025-06-10Clinical Trial Update: Belimumab (BENLYSTA®) Pregnancy Registry
Clinical trial update reporting on the completed pregnancy registry for belimumab (BENLYSTA) in patients with systemic lupus erythematosus.
-
CLINICAL_TRIALS research · 2025-06-10Clinical Trial Update: The Frequency of Thiopurine Methyltransferase Polymorphism in Systemic Lupus Erythematosus SLE
The completed trial investigated how common thiopurine methyltransferase (TPMT) genetic polymorphisms are among patients with systemic lupus…
-
CLINICAL_TRIALS research · 2025-06-08Clinical Trial Update: Fatigue in Lupus Intervention Programmes (FLIP) [NA]
A clinical trial update for the Fatigue in Lupus Intervention Programmes (FLIP) evaluating fatigue management in systemic lupus erythematosu…
-
CLINICAL_TRIALS research · 2025-06-05Clinical Trial Update: Teams Engaged in Accessible Mental Health Interventions for Lupus Erythematosus and Dermatomyositis Stress [NA]
Clinical trial status update about teams developing accessible mental health interventions for lupus erythematosus and dermatomyositis; the …
-
CLINICAL_TRIALS research · 2025-06-05Clinical Trial Update: Long-Term Outcomes in SLE at Peking University People's Hospital
A long-term outcomes study of systemic lupus erythematosus being conducted at Peking University People's Hospital; the trial is currently re…
-
CLINICAL_TRIALS withdrawal · 2025-06-05Clinical Trial Update: A Pilot Study to Explore the Role of Gut Flora in Lupus
A pilot clinical trial sponsored by ProgenaBiome investigating the role of gut flora in lupus has been withdrawn.
-
CLINICAL_TRIALS research · 2025-06-03Clinical Trial Update: A Phase Ib Study of QLS4131 in Subjects With Systemic Lupus Erythematosus [Phase 1]
This document reports an early-phase (Phase Ib) trial of QLS4131 for systemic lupus erythematosus. The study is listed as not yet recruiting…
-
CLINICAL_TRIALS research · 2025-06-03Clinical Trial Update: Occupational and Environmental Causes of Autoimmune Diseases [NA]
A clinical trial update indicates a study examining occupational and environmental factors in autoimmune diseases has completed. Conditions …
-
CLINICAL_TRIALS research · 2025-06-03Clinical Trial Update: BAFF CAR-T Cells (LMY-920) for Systemic Lupus Erythematosus [Phase 1]
This clinical trial update reports a Phase 1 study evaluating BAFF CAR-T cells (LMY-920) for systemic lupus erythematosus, currently recruit…
-
CLINICAL_TRIALS research · 2025-06-03Clinical Trial Update: Medical Follow-up of New Cases of Polyarthritis in Children and Young Adults
This clinical trial update notes ongoing recruitment for a longitudinal follow-up study of newly diagnosed polyarthritis in children and you…
-
CLINICAL_TRIALS research · 2025-05-29Clinical Trial Update: NK010 or NK042 in Combination With Rituximab for Refractory Systemic Lupus Erythematosus/Lupus Nephritis [Phase 1]
A Phase 1 clinical trial evaluating NK010 or NK042 in combination with Rituximab for refractory systemic lupus erythematosus and refractory …
-
CLINICAL_TRIALS trial_result · 2025-05-29Clinical Trial Update: Autologous CD19 Car T-Cell Therapy For Severe Refractory Systemic Lupus Erythematosus (SLE) [Phase 1]
A Phase 1 clinical trial is evaluating autologous CD19 CAR T-cell therapy for severe refractory systemic lupus erythematosus, and the study …
-
CLINICAL_TRIALS trial_result · 2025-05-25Clinical Trial Update: Anti-CD19 CAR-NK Cells in Refractory/Relapsed Systemic Lupus Erythematosus [Phase 1]
A Phase 1 clinical trial is evaluating anti-CD19 CAR-NK cells in patients with refractory/relapsed systemic lupus erythematosus. The study i…
-
CLINICAL_TRIALS trial_result · 2025-05-23Clinical Trial Update: Transcutaneous Vagus Nerve Stimulation in SLE [Phase 2]
A Phase 2 clinical trial investigating transcutaneous vagus nerve stimulation for systemic lupus erythematosus is not yet recruiting, sponso…
-
CLINICAL_TRIALS research · 2025-05-20Clinical Trial Update: A Study of OL-108 in Relapsed/Refractory Autoimmune Diseases [Phase 1]
A Phase 1 study evaluating OL-108 in relapsed/refractory autoimmune diseases is currently recruiting, including systemic lupus erythematosus…